| Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
| c.4930C>T | p.Arg1644X | Heterozygous | Mutation |
| wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
| CGA | Arg | TGA | Stop | C->T | Ts |
| Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
| cb EGF-like #23 | No | Yes |
| At the mRNA level | On restriction map |
| NA | New restriction site(s): Nla III Lost restriction site(s): none |
| Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
| UKD05LON F0010 I13 | Proband | NA | NA | U.K. |
| Phenotypic group | Disease |
| NA | Incomplete MFS |
| Symptom | Age |
| C-Minor cardiovascular involvement | 43 |
| Reference ID | PubMed ID | Reference |
| 96 | 17657824 | Comeglio P, Johnson P, Arno G, Brice G, Evans A, Aragon-Martin J, da Silva FP, Kiotsekoglou A, Child A. "The importance of mutation detection in Marfan syndrome and Marfan-related disorders: report of 193 FBN1 mutations". Hum Mutat. 2007 Sep;28(9):928. |